NCT05178069View on ClinicalTrials.gov

LGG Supplementation in Patients With AUD and ALD

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

August 31, 2026

Study Completion Date

February 28, 2027

Conditions
Alcohol Use DisorderAlcohol-associated Liver Disease
Interventions
DRUG

: Placebo for Probiotic

Capsule manufactured without active ingredients.

DIETARY_SUPPLEMENT

Lactobacillus Rhamnosus GG

Probiotic nutritional supplement; Lactobacillus Rhamnosus G

Trial Locations (1)

40202

RECRUITING

University of Louisville Hospital, Louisville

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of Louisville

OTHER